Temporary Transvenous Pacemaker Placement by Intracavitary Electrocardiogram Monitoring

NCT ID: NCT04905199

Last Updated: 2021-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-25

Study Completion Date

2022-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Traditional temporary pacing catheter insertion by intracavitary electrocardiogram (IC-ECG) monitoring which only monitoring tip polar, the negative one. The investigators modified the technique by monitoring both negative and positive polar which will be precisely locating catheter tip and indicating the direction of the catheter tip.

Extensively used temporary pacing catheter tip has two electrodes which are about 1 cm apart. Distal electrode is negative (-) and active, proximal electrode is positive (+) and indifferent.

Investigators use both distal (-) and proximal (+) electrodes which can be attached to any two of the V leads, record as V(-) and V(+). Monitoring positions of the electrodes by V(-) and V(+) could provide more information about the tip position. Comparing the QRS amplitudes between V(-) and V(+), when catheter tip enters right ventricle chamber: the case of V(-) \> V(+) infers tip toward apex ventricle wall ; conversely, the case of V(-)\<V(+) indicates tip directs to outflow tract.

The investigators hypothesis this monitoring will help precisely placement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bradycardia; Syncope Bradyarrhythmia Brady-tachy Syndrome Tachycardia Bradycardia AVB - Atrioventricular Block Tachyarrhythmia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-floating catheter

When using non-floating catheter.

Temporary transvenous cardiac pacing

Intervention Type PROCEDURE

Transvenous temporary pacemaker insertion by modified IC-ECG monitoring.

Floating catheter

When using floating catheter.

Temporary transvenous cardiac pacing

Intervention Type PROCEDURE

Transvenous temporary pacemaker insertion by modified IC-ECG monitoring.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Temporary transvenous cardiac pacing

Transvenous temporary pacemaker insertion by modified IC-ECG monitoring.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with indication of temporary transvenous pacing

Exclusion Criteria

* Not applicate to IC-ECG monitoring.
Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hunan Provincial People's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Meng Liu

Attending physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiaotong Han, MD

Role: STUDY_DIRECTOR

Hunan Provincial People's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hunan Provincial People's hospital

Changsha, Hunan, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Meng Liu, MD

Role: CONTACT

Phone: +8615084858606

Email: [email protected]

Xiaotong Han, MD

Role: CONTACT

Phone: +8613725870299

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jie Zhong, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202084

Identifier Type: -

Identifier Source: org_study_id